glutamine has been researched along with Cancer of Pelvis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Algara López, M; Fernández-Velilla Cepria, E; Foro Arnalot, P; Lacruz Bassols, M; Lozano Galán, J; Membrive Conejo, I; Quera Jordana, J; Reig Castillejo, A; Rodríguez de Dios, N; Sanz Latiesas, J | 1 |
Dick, SJ; Engeler, GP; Frank, AR; Kozelsky, TF; Martenson, JA; McKone, TK; Meyers, GE; Moore, RL; Novotny, PJ; Pilepich, MV; Shanahan, TG; Sloan, JA; Urias, RE | 1 |
1 trial(s) available for glutamine and Cancer of Pelvis
Article | Year |
---|---|
Phase III double-blind study of glutamine versus placebo for the prevention of acute diarrhea in patients receiving pelvic radiation therapy.
Topics: Acute Disease; Adenocarcinoma; Administration, Oral; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Diarrhea; Double-Blind Method; Female; Glutamine; Humans; Male; Middle Aged; Pelvic Neoplasms; Pelvis; Placebos; Quality of Life; Radiotherapy | 2003 |
1 other study(ies) available for glutamine and Cancer of Pelvis
Article | Year |
---|---|
Prevention of acute radiation enteritis: efficacy and tolerance of glutamine.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Diarrhea; Female; Fluorouracil; Glutamine; Humans; Male; Maximum Tolerated Dose; Middle Aged; Pelvic Neoplasms; Prognosis; Prospective Studies; Quality of Life | 2011 |